Your browser doesn't support javascript.
loading
Beyond Diet and Exercise: The Impact of Gut Microbiota on Control of Obesity.
Kamal, Farah Deeba; Dagar, Mehak; Reza, Taufiqa; Karim Mandokhail, Alishba; Bakht, Danyal; Shahzad, Muhammad Waqas; Silloca-Cabana, Elizabeth O; Mohsin, Syed Naveed; Chilla, Srikar P; Bokhari, Syed Faqeer Hussain.
Afiliação
  • Kamal FD; Emergency, Portiuncula University Hospital, Ballinasloe, IRL.
  • Dagar M; Internal Medicine, Himalayan Institute of Medical Sciences, New Delhi, IND.
  • Reza T; Medicine, Avalon University School of Medicine, Youngstown, USA.
  • Karim Mandokhail A; Radiology, Quetta Institute of Medical Sciences, Quetta, PAK.
  • Bakht D; Medicine and Surgery, Mayo Hospital, Lahore, PAK.
  • Shahzad MW; Medicine, Gujranwala Medical College, Gujranwala, PAK.
  • Silloca-Cabana EO; Medicine, Wyckoff Heights Medical Center, Brooklyn, USA.
  • Mohsin SN; Orthopedics, St. James's Hospital, Dublin, IRL.
  • Chilla SP; General Surgery, Cavan General Hospital, Cavan, IRL.
  • Bokhari SFH; Medicine, CARE Hospitals, Hyderabad, IND.
Cureus ; 15(11): e49339, 2023 Nov.
Article em En | MEDLINE | ID: mdl-38143595
ABSTRACT
Obesity, a widespread health concern characterized by the excessive accumulation of body fat, is a complex condition influenced by genetics, environment, and social determinants. Recent research has increasingly focused on the role of gut microbiota in obesity, highlighting its pivotal involvement in various metabolic processes. The gut microbiota, a diverse community of microorganisms residing in the gastrointestinal tract, interacts with the host in a myriad of ways, impacting energy metabolism, appetite regulation, inflammation, and the gut-brain axis. Dietary choices significantly shape the gut microbiota, with diets high in fat and carbohydrates promoting the growth of harmful bacteria while reducing beneficial microbes. Lifestyle factors, like physical activity and smoking, also influence gut microbiota composition. Antibiotics and medications can disrupt microbial diversity, potentially contributing to obesity. Early-life experiences, including maternal obesity during pregnancy, play a vital role in the developmental origins of obesity. Therapeutic interventions targeting the gut microbiota, including prebiotics, probiotics, fecal microbiota transplantation, bacterial consortium therapy, and precision nutrition, offer promising avenues for reshaping the gut microbiota and positively influencing weight regulation and metabolic health. Clinical applications of microbiota-based therapies are on the horizon, with potential implications for personalized treatments and condition-based interventions. Emerging technologies, such as next-generation sequencing and advanced bioinformatics, empower researchers to identify specific target species for microbiota-based therapeutics, opening new possibilities in healthcare. Despite the promising outlook, microbiota-based therapies face challenges related to microbial selection, safety, and regulatory issues. However, with ongoing research and advances in the field, these challenges can be addressed to unlock the full potential of microbiota-based interventions.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article